S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Mersana Therapeutics Insider Trades

+0.33 (+1.59 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $21.09
50-Day Range
MA: $23.94
52-Week Range
Now: $21.09
Volume1.14 million shs
Average Volume1.62 million shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling Activity

Insider Ownership Percentage: 5.30%
Insider Buying (Last 12 Months): $38,946,540.56
Insider Selling (Last 12 Months): $1,932,647.08

Insider Buying and Selling by Quarter

Mersana Therapeutics (NASDAQ MRSN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2021Andrew A F HackDirectorBuy250,000$18.36$4,590,000.00  
1/8/2021Andrew A F HackDirectorBuy100,000$18.39$1,839,000.00  
1/4/2021Ashish MandeliaVPSell247$26.76$6,609.72  
12/21/2020Timothy B LowingerInsiderSell8,203$25.60$209,996.801,874  
11/20/2020Timothy B LowingerInsiderSell8,203$23.05$189,079.151,874  
10/21/2020Timothy B LowingerInsiderSell4,101$17.50$71,767.501,875  
9/21/2020Timothy B LowingerInsiderSell20,614$20.66$425,885.2416,160  
9/14/2020Eva M JackInsiderSell35,248$22.00$775,456.0035,248  
7/2/2020Ashish MandeliaVPSell3,383$22.49$76,083.67
6/1/2020Lawrence M AllevaDirectorBuy1,085$22.95$24,900.75385  
4/13/2020Scott D SandellMajor ShareholderSell20,914$8.50$177,769.00  
4/7/2020Andrew A F HackDirectorBuy3,445,667$9.43$32,492,639.81538,599  
3/5/2019Enterprise Associates 14 NewMajor ShareholderBuy3,750,000$4.00$15,000,000.00  
9/24/2018Timothy B LowingerInsiderSell3,500$11.63$40,705.00  
8/27/2018Timothy B LowingerInsiderSell3,500$13.15$46,025.00  
7/23/2018Timothy B LowingerInsiderSell3,500$11.06$38,710.00  
7/3/2017M James BarrettMajor ShareholderBuy1,000,000$15.00$15,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.